These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 12434178

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Phe22]-big endothelin-1[19-37]: a new and potent inhibitor of the endothelin-converting enzyme.
    Claing A, Neugebauer W, Yano M, Rae GA, D'Orléans-Juste P.
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S72-4. PubMed ID: 8587472
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Pharmacologic evidence for the specificity of the phosphoramidon-sensitive endothelin-converting enzyme for big endothelin-1.
    Télémaque S, Gratton JP, Claing A, D'Orléans-Juste P.
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S85-9. PubMed ID: 7510007
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities.
    Rizzi A, Calo G, Battistini B, Regoli D.
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S58-61. PubMed ID: 9595400
    [Abstract] [Full Text] [Related]

  • 29. Contractile effect of big endothelin-1 and its conversion to endothelin-1 in rabbit cerebral arteries.
    Petersson J, Hanson GC, Lindberg BF, Högestätt ED.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):656-61. PubMed ID: 8938666
    [Abstract] [Full Text] [Related]

  • 30. Role of endothelin-converting enzyme, chymase and neutral endopeptidase in the processing of big ET-1, ET-1(1-21) and ET-1(1-31) in the trachea of allergic mice.
    De Campo BA, Goldie RG, Jeng AY, Henry PJ.
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():353S-356S. PubMed ID: 12193121
    [Abstract] [Full Text] [Related]

  • 31. Molecular pharmacology of endothelin converting enzymes.
    Turner AJ, Murphy LJ.
    Biochem Pharmacol; 1996 Jan 26; 51(2):91-102. PubMed ID: 8615890
    [Abstract] [Full Text] [Related]

  • 32. Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum.
    Emoto N, Yanagisawa M.
    J Biol Chem; 1995 Jun 23; 270(25):15262-8. PubMed ID: 7797512
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Diabetes-associated changes and role of N epsilon-(carboxymethyl)lysine in big ET-1-induced coronary vasoconstriction.
    Matsumoto T, Ozawa Y, Taguchi K, Kobayashi T, Kamata K.
    Peptides; 2010 Feb 23; 31(2):346-53. PubMed ID: 19962413
    [Abstract] [Full Text] [Related]

  • 35. Effect of the novel endothelin(A) receptor antagonist LU 208075 on contraction and relaxation of isolated rat basilar artery.
    Vatter H, Zimmermann M, Jung C, Weyrauch E, Lang J, Seifert V.
    Clin Sci (Lond); 2002 Aug 23; 103 Suppl 48():408S-413S. PubMed ID: 12193134
    [Abstract] [Full Text] [Related]

  • 36. [Phe21]big endothelin-1(18-34) and [Ala31]big endothelin-1(18-34) inhibit the human endothelin-converting enzyme-1 (ECE-1) expressed in CHO-K1 cells in a different fashion.
    Liu W, Takayanagi R, Ito T, Oba K, Nawata H.
    FEBS Lett; 1997 Dec 22; 420(1):103-6. PubMed ID: 9450558
    [Abstract] [Full Text] [Related]

  • 37. Disulfide bonds in big ET-1 are essential for the specific cleavage at the Trp(21)-Val(22) bond by soluble endothelin converting enzyme-1 from baculovirus/insect cells.
    Fahnoe DC, Johnson GD, Herman SB, Ahn K.
    Arch Biochem Biophys; 2000 Jan 15; 373(2):385-93. PubMed ID: 10620363
    [Abstract] [Full Text] [Related]

  • 38. Characterization of endothelin converting enzyme from intact cells of a permanent human endothelial cell line, EA.hy926.
    Ahn K, Pan SM, Zientek MA, Guy PM, Sisneros AM.
    Biochem Mol Biol Int; 1996 Jun 15; 39(3):573-80. PubMed ID: 8828809
    [Abstract] [Full Text] [Related]

  • 39. Structure activity relationship of phosphoramidon derivatives for in vivo endothelin-converting-enzyme inhibition.
    Bigaud M, Hauss B, Schalk C, Jauch MF, D'Orchymont H.
    Fundam Clin Pharmacol; 1994 Jun 15; 8(2):155-61. PubMed ID: 8020872
    [Abstract] [Full Text] [Related]

  • 40. Endothelin-converting enzyme and its in vitro and in vivo inhibition.
    Yano M, Okada K, Takada J, Hioki Y, Matsuyama K, Fukuroda T, Noguchi K, Nishikibe M, Ikemoto F.
    J Cardiovasc Pharmacol; 1991 Jun 15; 17 Suppl 7():S26-8. PubMed ID: 1725349
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.